FineMark National Bank & Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
|
|||||
|
2025
Q1 | $389K | Sell |
|
|||||
|
2024
Q4 | $442K | Sell |
|
|||||
|
2024
Q3 | $505K | Sell |
|
|||||
|
2024
Q2 | $488K | Hold |
|
|||||
|
2024
Q1 | $499K | Buy |
|
|||||
|
2023
Q4 | $435K | Hold |
|
|||||
|
2023
Q3 | $356K | Sell |
|
|||||
|
2023
Q2 | $412K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $225K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $238K | Buy |
|
|||||
|
2021
Q4 | $293K | Hold |
|
|||||
|
2021
Q3 | $329K | Buy |
|
|||||
|
2021
Q2 | $344K | Sell |
|
|||||
|
2021
Q1 | $350K | Buy |
|
|||||
|
2020
Q4 | $327K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $491K | Hold |
|
|||||
|
2018
Q1 | $453K | Hold |
|
|||||
|
2017
Q4 | $438K | Hold |
|
|||||
|
2017
Q3 | $447K | Sell |
|
|||||
|
2017
Q2 | $402K | Buy |
|
|||||
|
2017
Q1 | $336K | Buy |
|
|||||
|
2016
Q4 | $284K | Hold |
|
|||||
|
2016
Q3 | $318K | Hold |
|
|||||
|
2016
Q2 | $260K | Hold |
|
|||||
|
2016
Q1 | $248K | Hold |
|
|||||
|
2015
Q4 | $337K | Hold |
|
|||||
|
2015
Q3 | $299K | Sell |
|
|||||
|
2015
Q2 | $663K | Buy |
|
|||||
|
2015
Q1 | $548K | Buy |
|
|||||
|
2014
Q4 | $304K | Hold |
|
|||||
|
2014
Q3 | $254K | Hold |
|
|||||
|
2014
Q2 | $251K | Hold |
|
|||||
|
2014
Q1 | $232K | Hold |
|
|||||
|
2013
Q4 | $212K | Buy |
|
|||||
|
2013
Q3 | $200K | Buy |
|